Literature DB >> 18250923

Risk factors for antibiotic resistance in Streptococcus pneumoniae.

K P Klugman1.   

Abstract

Streptococcus pneumoniae (the pneumococcus) is the leading vaccine-preventable cause of death in children and adults. The management of pneumococcal infections is complicated by the development of resistance to antimicrobials. Risk factors for increased resistance include young age, isolation from the upper respiratory tract, hospitalisation, residence in an urban area, day care attendance, previous exposure to antibiotics, female gender, exposure to specific serotypes and clones, HIV infection and exposure to a class of drug to which resistance can be easily selected from a susceptible population of organisms. Conjugate pneumococcal vaccine affords protection from resistant strains belonging to vaccine serotypes, but resistance is emerging in non-vaccine types.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18250923

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010.

Authors:  Claire von Mollendorf; Cheryl Cohen; Linda de Gouveia; Vanessa Quan; Susan Meiring; Charles Feldman; Keith P Klugman; Anne von Gottberg
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.

Authors:  Penny Crowther-Gibson; Cheryl Cohen; Keith P Klugman; Linda de Gouveia; Anne von Gottberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

Review 3.  Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.

Authors:  Lindsay Kim; Lesley McGee; Sara Tomczyk; Bernard Beall
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  Corona Virus Disease 2019 patients with different disease severity or age range: A single-center study of clinical features and prognosis.

Authors:  Lingyun Ren; Dan Yao; Zuowei Cui; Shanshan Chen; Hong Yan
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.